Multidisciplinary care of the hepatocellular carcinoma patient

Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary Care

Volumn , Issue , 2011, Pages 81-88

  Contreras, Carlo M ^a   Vauthey, Jean Nicolas ^a   McMasters, Kelly M ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

HCC care; HCC treatment; Hepatocellular carcinoma; Multidisciplinary care

Indexed keywords

EID: 84862548205     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-522-4_6     Document Type: Chapter

References (29)

1. Zeuzem S, Feinman SV, Rasenack J et al (2000) Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 343:1666-1672
2. Chronic Hepatitis C: Current Disease Management Hepatitis, vol. (2009) Bethesda: National Digestive Diseases Information Clearinghouse, 2006: NIH Publication No. 07-4230.
3. Dienstag JL (2008) Drug therapy: hepatitis B virus infection. N Engl J Med 359:1486-1500
4. Zhang BH, Yang BH, Tang ZY (2004) Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130:417-22
5. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208-1236
6. Poon RTP, Fan ST (2003) Evaluation of the new AJCC/UICC staging system for hepa-tocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin N Am 12:35-50
7. Ramacciato G, Mercantini P, Cautero N et al (2005) Prognostic evaluation of the new American joint committee on cancer/international union against cancer staging system for hepatocellular carcinoma: Analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. Ann Surg Oncol 12:289-297
8. Varotti G, Ramacciato G, Ercolani G et al (2005) Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: Multicentric study on 393 cirrhotic resected patients. Eur J Surg Oncol 31:760-767
9. Wu CC, Cheng SB, Ho WM et al (2005) Liver resection for hepatocellular carcinoma in patients with cirrhosis. Br J Surg 92:348-355
10. Lei HJ, Chau GY, Lui WY et al (2006) Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J Am Coll Surg 203:426-435
11. Kee KM, Wang JH, Lee CM et al (2007) Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5, 613 cases from a medical center in southern Taiwan. Int J Cancer 120:2650-2655
12. Vauthey JN, Ribero D, Abdalla EK et al (2007) Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg 204:1016-1027
13. Pomfret EA, Washburn K, Wald C et al (2010) Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 16:262-278
14. Ariff B, Lloyd CR, Khan S et al (2009) Imaging of liver cancer. World J Gastroenterol 15:1289-1300
15. Ribero D, Abdalla EK, Madoff DC et al (2007) Portal vein embolization before major hepa-tectomy and its effects on regeneration, resectability and outcome. Br J Surg 94:1386-1394
16. Llovet JM, Chen Y, Wurmbach E et al (2006) A molecular signature to discriminate dys-plastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 131: 1758-1767
17. Wurmbach E, Chen Y-B, Khitrov G et al (2007) Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45:938-947
18. Vauthey JN, Lauwers GY, Esnaola NF et al (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20:1527-1536
19. Hoshida Y, Villanueva A, Kobayashi M et al (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359:1995-2004
20. Vauthey JN, Klimstra D, Franceschi D et al (1995) Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169:28-34
21. Yeo W, Mok TS, Zee B et al (2005) A randomized phase III study of doxorubicin versus cis-platin/interferon {alpha}-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. J Natl Cancer Inst 97:1532-1538
22. Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378-390
23. Llovet JM, Bruix J (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48(Suppl 1):S20-S37
24. Kishi Y, Madoff DC, Abdalla EK et al (2008) Is embolization of segment 4 portal veins before extended right hepatectomy justified? Surgery 144:744-751
25. Palavecino M, Chun YS, Madoff DC et al (2009) Major hepatic resection for hepatocellu-lar carcinoma with or without portal vein embolization: perioperative outcome and survival. Surgery 145:399-405
26. Lencioni R, Cioni D (2007) Percutaneous methods for ablation of hepatic neoplasms. In: Blumgart L (ed) Surgery of the Liver, Biliary Tract, and Pancreas, 4th edn. Elsevier, New York, pp 1269-1277
27. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocel-lular carcinoma: chemoembolization improves survival. Hepatology 37:429-442
28. Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-699
29. Yao FY, Ferrell L, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394-403